Compare Global X Autonomous & Electric Vehicles (DRIV) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Autonomous & Electric Vehicles vs Johnson & Johnson — how do they compare? Global X Autonomous & Electric Vehicles trades at $35.85, while Johnson & Johnson trades at $260.51 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while Global X Autonomous & Electric Vehicles pays none, and Johnson & Johnson is trading nearer its 52-week high, Global X Autonomous & Electric Vehicles nearer its low. Which is the better fit depends on your goals.
| DRIV | JNJ | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $42.53 | $267.24 |
52-Week Low | $25.23 | $172.78 |
Market Cap | — | $626.09B |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DRIV trades at $35.92, up 0.98% on the day, with a bullish technical signal supported by moving averages and ADX indicators. The stock shows strong momentum, though the short-term RSI suggests overbought conditions. Recent news highlights global EV sales growth and China's aggressive expansion, benefiting the sector. A dividend of $0.07 is scheduled for July 2026, adding income potential.
Outlook remains positive due to sector tailwinds from rising EV adoption and fuel price pressures. Key risks include competitive threats from Chinese automakers and regulatory delays. Analysts are generally bullish, but investors should monitor valuation gaps and execution risks amid rapid industry shifts.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Autonomous & Electric Vehicles
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
